To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:22 Issue:1 Number:1 ISSN#:2564-2537
Author Verified
ACE Report #13444
Ace Report Cover Foot & Ankle

Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis

How to Cite

OrthoEvidence. Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis. ACE Report. 2021;22(1):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar Fasciitis

Foot Ankle Int. 2021 Mar;42(3): 305-313.

Contributing Authors: J Elizondo-Rodríguez M Simental-Mendía V Peña-Martínez F Vilchez-Cavazos Y Tamez-Mata C Acosta-Olivo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seventy-one patients with ≥2 months of persisting heel pain at the origin of the plantar fascia unresponsive to conventional therapies were randomized to receive a single injection of ropivacaine (5 mL; n=23), an intra-lesional injection of betamethasone sodium phosphate (1 mL; n=25), or an intralesional injection of 200 U of botulinum toxin A (BoNT-A; n=23) injection, administered using ultrasoun...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.